Aurora Financial JournalALK-Abelló (ALK-B.CO)
Nasdaq Copenhagen · Pharmaceutical industry · Financial statements, TTM figures and earnings dates
In fiscal year 2025 (ended December 31, 2025), ALK-Abelló reported revenue of DKK 6.31B and net income of DKK 1.20B. Annual financial statements are available for fiscal years 2021 to 2025, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| DKK | FY2025 2025-12-31 | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | DKK 6.31B | DKK 5.54B | DKK 4.82B | DKK 4.51B | DKK 3.92B |
| Gross profit | DKK 4.23B | DKK 3.55B | DKK 3.04B | DKK 2.79B | DKK 2.40B |
| Operating income | DKK 1.65B | DKK 1.09B | DKK 666.0M | DKK 470.0M | DKK 292.0M |
| Net income | DKK 1.20B | DKK 815.0M | DKK 486.0M | DKK 335.0M | DKK 219.0M |
| Diluted EPS | DKK 540.00 | DKK 3.68 | DKK 2.20 | DKK 1.51 | DKK 0.99 |
| Cash flow | |||||
| Operating cash flow | DKK 1.82B | DKK 1.21B | DKK 667.0M | DKK 416.0M | DKK 468.0M |
| Capital expenditure | DKK 276.0M | DKK 260.0M | DKK 310.0M | DKK 298.0M | DKK 218.0M |
| Free cash flow | DKK 1.54B | DKK 953.0M | DKK 357.0M | DKK 118.0M | DKK 250.0M |
| Balance sheet | |||||
| Cash and equivalents | DKK 1.24B | DKK 589.0M | DKK 474.0M | – | – |
| Total assets | DKK 9.06B | DKK 8.25B | DKK 6.73B | DKK 6.31B | DKK 5.83B |
| Total liabilities | DKK 2.61B | DKK 2.87B | DKK 2.28B | DKK 2.32B | DKK 2.35B |
| Total debt | DKK 0 | DKK 671.0M | DKK 261.0M | DKK 208.0M | DKK 226.0M |
| Shareholders' equity | DKK 6.45B | DKK 5.37B | DKK 4.45B | DKK 3.99B | DKK 3.48B |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in DKK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full ALK-B.CO page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open ALK-B.CO financials →